Chad J. Kugler

Vascular Solutions LLC operates as a medical device company, which engages in the provision of clinical solutions for diagnostic and interventional vascular procedures. Its products include GuideLiner, Langston, Pronto V4, and D-Stat Dry. The company was founded by Howard C. Root on December 20, 1996 and is headquartered in Minneapolis, MN.

Prospex Medical, Inc. manufactures medical devices and products. It is an medical technology incubator. The company is founded by Michael Berman, Robert E. Atkinson & Chad J. Kugler and is headquartered in Arden Hills, MN.

Torax Medical Inc. designs and develops medical devices to treat chronic diseases related to defective sphincter muscles. Its technology platform, Magnetic Sphincter Augmentation (MSA), uses attraction forces to augment weak or defective sphincter muscles to treat gastroesophageal reflux disease (GERD) and fecal incontinence (FI). The firm's products include LINX, a reflux management system for the treatment of GERD; and FENIX, a continence restoration system for the treatment of FI. The company was founded by Todd Berg in 2002 and is headquartered in Shoreview, MN.

Apnex Medical, Inc. manufactured medical devices. It developed a proprietary active implantable medical device for the treatment of obstructive sleep apnea (OSA). The company was founded by Chad J. Kugler, Michael L. Berman and Robert E. Atkinson in 2006 and was headquartered in St. Paul, MN.

Part of Cardinal Health, Inc., SciMed Ltd. is a British company that manufactures peripheral vascular and transcranial Doppler medical diagnostic devices. The company is based in Cheadle, UK. SciMed was acquired by VIASYS Healthcare, Inc. on January 14, 2003.

Part of Cardinal Health, Inc., TERAMed, Inc. designs, develops, and manufactures endovascular graft systems. The company is based in Maple Grove, MN. TERAMed was acquired by Cordis Corp., part of Cardinal Health, Inc. from October 04, 2015 on December 18, 2001.

Bridgepoint Medical, Inc. develops interventional technology in the field of cardiology. It focuses on developing innovative and proprietary technology in the field of interventional cardiology for access to and treatment of chronic total occlusions. The company was founded by Michael L. Berman, Chad J Kugler and Robert E Atkinson in 2005 and is headquartered in Plymouth, MN.